Ramamurthy, Chethan
Godwin, James L.
Borghaei, Hossein
Article History
First Online: 22 May 2017
Compliance with Ethical Standards
:
: Chethan Ramamurthy declares that he has no conflict of interest.James L. Godwin declares that he has no conflict of interest.Hossein Borghaei has received compensation from Genentech, Lilly, Bristol-Myers Squibb, Celgene, Clovis, Pfizer, Merck, EMD-Serono, Trovagene, and AstraZeneca for service on advisory boards; has received clinical trial funding from Merck/Celgene and Millennium; and has received compensation from the University of Pennsylvania for serving on a Data Safety Monitoring Board.
: This article does not contain any studies with human or animal subjects performed by any of the authors.